Integration of in vitro data from three dimensionally cultured HepaRG cells and physiologically based pharmacokinetic modeling for assessment of acetaminophen hepatotoxicity
- 18 April 2020
- journal article
- research article
- Published by Elsevier BV in Regulatory Toxicology and Pharmacology
- Vol. 114, 104661
- https://doi.org/10.1016/j.yrtph.2020.104661
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development (2018YFC1602602)
- National Natural Science Foundation of China (81430090)
- Unilever International Collaborative Project (MA-2015-00410)
This publication has 68 references indexed in Scilit:
- Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in ChildrenCPT: Pharmacometrics & Systems Pharmacology, 2013
- Drug-induced acute liver failure: Results of a U.S. multicenter, prospective studyHepatology, 2010
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Acquired Resistance to Acetaminophen Hepatotoxicity is Associated with Induction of Multidrug Resistance-Associated Protein 4 (Mrp4) in Proliferating HepatocytesToxicological Sciences, 2008
- The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobioticsChemico-Biological Interactions, 2007
- Mitochondrial involvement in drug-induced hepatic injuryChemico-Biological Interactions, 2006
- THECYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITYDrug Metabolism and Disposition, 2004
- Increasing the Aqueous Solubility of Acetaminophen in the Presence of Polyvinylpyrrolidone and Investigation of the Mechanisms InvolvedDrug Development and Industrial Pharmacy, 2003
- Infection of a human hepatoma cell line by hepatitis B virusProceedings of the National Academy of Sciences of the United States of America, 2002
- Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1982